100 filings
8-K
Biohaven Pharmaceutical Holding Co Ltd.
3 Oct 22
Termination of a Material Definitive Agreement
5:18pm
8-K
Biohaven Pharmaceutical Holding Co Ltd.
29 Sep 22
Submission of Matters to a Vote of Security Holders
11:44am
8-K
Biohaven Pharmaceutical Holding Co Ltd.
27 Sep 22
Regulation FD Disclosure
5:23pm
8-K
Biohaven Pharmaceutical Holding Co Ltd.
23 Sep 22
Regulation FD Disclosure
6:23am
8-K
Biohaven Pharmaceutical Holding Co Ltd.
23 Sep 22
Other Events
6:15am
8-K
9dgc9
19 Sep 22
Other Events
5:20pm
8-K
r2l tqy4a
19 Sep 22
Biohaven Announces Record Date for Anticipated Spin-Off
6:40am
8-K
7j1kp0vk
5 Aug 22
Biohaven Reports Second Quarter 2022 Financial Results and Reports Recent Business Developments
4:07pm
8-K
gkvjonl1ce4m1 h9v
28 Jun 22
Other Events
5:29pm
8-K
tgesub2mm50j0kczzt6
10 May 22
Entry into a Material Definitive Agreement
9:42pm
8-K
n936fhg35nm9x2ka0ch
10 May 22
Biohaven Reports First Quarter 2022 Financial Results and Reports Recent Business Developments
7:43am
8-K
0xw7qx2j0 m6p5kt01
10 May 22
Pfizer to Acquire Biohaven Pharmaceuticals
7:16am
8-K
4f2ax 22p
29 Apr 22
Submission of Matters to a Vote of Security Holders
5:22pm
8-K
c8o 3bcvc73dposo02cj
15 Apr 22
Departure of Directors or Certain Officers
2:23pm
8-K
yyu72ef183g2o 1hwsx6
5 Apr 22
Completion of Acquisition or Disposition of Assets
4:38pm
8-K
wdjs mm52n9b8at
25 Feb 22
Biohaven Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Business Developments
4:13pm
8-K
p0p6p65 gfk
10 Jan 22
Biohaven Announces Preliminary 4Q2021 and Full Year Net Product Revenue for Nurtec Odt, Market Leading Novel Migraine Therapy
6:59am
8-K
qte2ki5r4e9809psgzth
7 Jan 22
Biohaven and Pfizer Complete Collaboration Transaction for Commercialization of Rimegepant and Zavegepant Outside United States
4:37pm
8-K
f010u2u1o3r
30 Dec 21
Departure of Directors or Certain Officers
4:42pm
8-K
n6d26vbzbnoq u4u
9 Dec 21
Biohaven Names Ceo Vlad Coric, MD, Chairman of the Board of Directors
5:24pm